仁和药业：8月22日召开董事会会议

Group 1 - The core point of the article is that Renhe Pharmaceutical (SZ 000650) held its 10th second board meeting on August 22, 2025, to review the 2025 semi-annual report and other documents [1] - For the year 2024, Renhe Pharmaceutical's revenue composition is 98.05% from the pharmaceutical industry and 1.95% from other businesses [1] - As of the report, Renhe Pharmaceutical has a market capitalization of 9.3 billion yuan [1]